全文获取类型
收费全文 | 2417篇 |
免费 | 216篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 84篇 |
妇产科学 | 20篇 |
基础医学 | 347篇 |
口腔科学 | 39篇 |
临床医学 | 321篇 |
内科学 | 496篇 |
皮肤病学 | 29篇 |
神经病学 | 155篇 |
特种医学 | 73篇 |
外科学 | 268篇 |
综合类 | 118篇 |
一般理论 | 1篇 |
预防医学 | 184篇 |
眼科学 | 70篇 |
药学 | 95篇 |
中国医学 | 2篇 |
肿瘤学 | 318篇 |
出版年
2021年 | 30篇 |
2019年 | 27篇 |
2018年 | 34篇 |
2017年 | 25篇 |
2015年 | 39篇 |
2014年 | 45篇 |
2013年 | 99篇 |
2012年 | 96篇 |
2011年 | 88篇 |
2010年 | 72篇 |
2009年 | 70篇 |
2008年 | 119篇 |
2007年 | 121篇 |
2006年 | 138篇 |
2005年 | 109篇 |
2004年 | 101篇 |
2003年 | 104篇 |
2002年 | 101篇 |
2001年 | 29篇 |
2000年 | 33篇 |
1999年 | 49篇 |
1998年 | 62篇 |
1997年 | 45篇 |
1996年 | 33篇 |
1995年 | 34篇 |
1994年 | 37篇 |
1993年 | 32篇 |
1992年 | 23篇 |
1991年 | 31篇 |
1990年 | 27篇 |
1989年 | 35篇 |
1988年 | 25篇 |
1987年 | 32篇 |
1985年 | 35篇 |
1984年 | 36篇 |
1983年 | 26篇 |
1982年 | 45篇 |
1981年 | 27篇 |
1980年 | 33篇 |
1979年 | 26篇 |
1978年 | 29篇 |
1977年 | 28篇 |
1976年 | 24篇 |
1975年 | 23篇 |
1974年 | 28篇 |
1973年 | 22篇 |
1972年 | 23篇 |
1971年 | 22篇 |
1970年 | 26篇 |
1969年 | 21篇 |
排序方式: 共有2650条查询结果,搜索用时 31 毫秒
1.
2.
3.
汽车机械学
Bobby是我的汽车修理师,他有一种我喜欢效仿的工作风格。首先他是一位伟大的诊断专家;如果你告诉他汽车出现了什么问题,他会帮你做出鉴别诊断。“运货车是否发动不着了?发动机是否转动?你是否听到了滴滴答答的声音?”问了几个问题后,他便会做出判断。比如我的发动机供不上汽油了,排除了几种可能性后他认为是由燃油泵造成的。 相似文献
4.
5.
6.
7.
Objective. To determine if patients treated at hospitals under different levels of financial strain from the Balanced Budget Act (BBA) of 1997 had differential changes in 30-day mortality, and whether vulnerable patient populations such as the uninsured were disproportionately affected.
Data Source. Hospital discharge data from all general acute care hospitals in Pennsylvania from 1997 to 2001.
Study Design. A multivariate regression analysis was performed retrospectively on 30-day mortality rates, using hospital discharge data, hospital financial data, and death certificate information from Pennsylvania.
Data Collection. We used 370,017 hospital episodes with one of four conditions identified by the Agency for Healthcare Research and Quality as inpatient quality indicators were extracted.
Principal Findings. The average magnitude of Medicare payment reduction on overall net revenues was estimated at 1.8 percent for hospitals with low BBA impact and 3.6 percent for hospitals with a high impact in 1998, worsening to 2 and 4.8 percent, respectively, by 2001. Operating margins decreased significantly over the time period for all hospitals ( p <.05). While unadjusted mortality rates demonstrated a disproportionate rise in mortality for patients from high impact hospitals from 1997 to 2000, adjusted analyses show no consistent, significant difference in the rate of change in mortality between high-impact and low-impact hospitals ( p =.04–.94). Similarly, uninsured patients did not experience greater increases in mortality in high-impact hospitals relative to low-impact hospitals.
Conclusions. An analysis of hospitalizations in the Commonwealth of Pennsylvania did not find an adverse impact of increased financial strain from the BBA on patient mortality either among all patients or among the uninsured. 相似文献
Data Source. Hospital discharge data from all general acute care hospitals in Pennsylvania from 1997 to 2001.
Study Design. A multivariate regression analysis was performed retrospectively on 30-day mortality rates, using hospital discharge data, hospital financial data, and death certificate information from Pennsylvania.
Data Collection. We used 370,017 hospital episodes with one of four conditions identified by the Agency for Healthcare Research and Quality as inpatient quality indicators were extracted.
Principal Findings. The average magnitude of Medicare payment reduction on overall net revenues was estimated at 1.8 percent for hospitals with low BBA impact and 3.6 percent for hospitals with a high impact in 1998, worsening to 2 and 4.8 percent, respectively, by 2001. Operating margins decreased significantly over the time period for all hospitals ( p <.05). While unadjusted mortality rates demonstrated a disproportionate rise in mortality for patients from high impact hospitals from 1997 to 2000, adjusted analyses show no consistent, significant difference in the rate of change in mortality between high-impact and low-impact hospitals ( p =.04–.94). Similarly, uninsured patients did not experience greater increases in mortality in high-impact hospitals relative to low-impact hospitals.
Conclusions. An analysis of hospitalizations in the Commonwealth of Pennsylvania did not find an adverse impact of increased financial strain from the BBA on patient mortality either among all patients or among the uninsured. 相似文献
8.
我的病人莎拉来就诊的主诉是呼吸困难,不过体检时除了有一点呼气时喘息,没有明显的其他症状,也没有发热,我还是先给她拍了个X线胸片。 相似文献
9.
AP de Moraes† ÉÂG de Arruda† MAV Vitoriano† MO de Moraes Filho‡ FÂF Bezerra‡ E de Magalhães Holanda§ MEA de Moraes‡ 《Journal of the European Academy of Dermatology and Venereology》2007,21(5):596-601
BACKGROUND: Seborrhoeic dermatitis (SD) is a common dermatosis in human immunodeficiency virus (HIV)-positive patients, many of whom do not respond satisfactorily to conventional topical treatments such as corticosteroids and antifungals. OBJECTIVE: A pilot study to investigate the efficacy and tolerability of pimecrolimus cream 1% in HIV-positive patients with facial SD. METHODS: In a single-centre study, 21 HIV-infected patients with mild to severe SD were treated twice daily with pimecrolimus cream 1% for 14 days. Thereafter, treatment was discontinued and patients followed up for 5 weeks. Skin involvement at baseline and on days 7, 14, 21, 35 and 49 was assessed using a four-point clinical score and digital photography. MAIN OUTCOME MEASURES: Efficacy and safety of pimecrolimus cream 1% treatment and incidence of relapse in the follow-up phase. Results Marked improvement was seen in clinical parameters at day 7, with >or= 90% patients clear of symptoms at day 14. Relapse was observed at day 35 but signs were milder than at baseline. All patients responded to therapy, despite their immunological status. Pimecrolimus did not alter CD4(+) and CD8(+) T-cell counts or viral load during the treatment period. CONCLUSION: Pimecrolimus cream represents a new, effective therapeutic option for facial SD in HIV patients. 相似文献
10.
Growth hormone effects on hypertrophic scar formation: a randomized controlled trial of 62 burned children 总被引:3,自引:0,他引:3
Gisele V. de Oliveira MD ; Arthur P. Sanford MD ; Kevin D. Murphy MD ; Hermes M. de Oliveira MD ; Judy P. Wilkins RGN ; Xiaowu Wu MD ; Hal K. Hawkins MD PhD ; Gregory Kitten PhD ; David L. Chinkes PhD ; Robert E. Barrow PhD ; David N. Herndon MD 《Wound repair and regeneration》2004,12(4):404-411
The hypercatabolism after massive pediatric burns has been effectively treated with recombinant human growth hormone, an anabolic agent that stimulates protein synthesis and abrogates growth arrest. While experimental studies have shown increased potential for fibrosis induced by growth hormone therapy, adverse effects on human scars have not been investigated. Our aim was to evaluate hypertrophic scar formation in 62 patients randomized to receive injections of 0.05 mg/kg/day of recombinant human growth hormone or placebo, from discharge until 1 year after burn. Scar scales were used to evaluate scar-severity at discharge, 6, 9, 12, and 18-24 months after burn, by three observers blinded to treatment. Computer-assisted planimetry allowed quantification of percentage of hypertrophic scar formation. Types I and III collagens were localized and quantified in scars and normal skin of patients from both groups, using immunohistochemistry with confocal laser microscopy analysis. Insulin-like growth factor-1 blood levels helped assess compliance. Statistical analysis showed that scar hypertrophy significantly increased from 6 to 12 months after injury in both groups, while decreasing at 18-24 months postburn. Types I and III collagens were statistically increased in the reticular layer of scars from both groups when compared to paired normal skin. Insulin-like growth factor-1 was significantly increased in the recombinant human growth factor-treated group. No differences were seen when recombinant human growth factor and control groups were compared using the scar scales, planimetry, or immunohistochemistry. We concluded that recombinant human growth hormone therapy did not adversely affect scar formation and should not contraindicate the administration of recombinant human growth hormone as a therapeutic approach to severely burned children. 相似文献